In vivo dosimetry: trends and prospects for brachytherapy
RIS ID
93928
Abstract
The error types during brachytherapy (BT) treatments and their occurrence rates are not well known. The limited knowledge is partly attributed to the lack of independent verification systems of the treatment progression in the clinical workflow routine. Within the field of in vivo dosimetry (IVD), it is established that real-time IVD can provide efficient error detection and treatment verification. However, it is also recognized that widespread implementations are hampered by the lack of available high-accuracy IVD systems that are straightforward for the clinical staff to use. This article highlights the capabilities of the state-of-the-art IVD technology in the context of error detection and quality assurance (QA) and discusses related prospects of the latest developments within the field. The article emphasizes the main challenges responsible for the limited practice of IVD and provides descriptions on how they can be overcome. Finally, the article suggests a framework for collaborations between BT clinics that implemented IVD on a routine basis and postulates that such collaborations could improve BT QA measures and the knowledge about BT error types and their occurrence rates.
Grant Number
NHMRC/573428
Publication Details
Kertzscher, G., Rosenfeld, A., Beddar, S., Tanderup, K. & Cygler, J. (2014). In vivo dosimetry: trends and prospects for brachytherapy. British Journal of Radiology, 87 (1041), 1-16.